Advantage Investment Management’s Teladoc Health TDOC Stock Holding History

Advantage Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$32K	Sell	483 -167	-26%	-$11K	0.02%	426
2019 Q2	$43K	Sell	650 -50	-7%	-$2.91K	0.03%	376
2019 Q1	$39K	Hold	700	–	–	0.03%	396
2018 Q4	$35K	Sell	700 -146	-17%	-$8.93K	0.03%	403
2018 Q3	$73K	Buy	846 +46	+6%	+$3.28K	0.05%	328
2018 Q2	$46K	Buy	800 +100	+14%	+$4.88K	0.03%	381
2018 Q1	$28K	Hold	700	–	–	0.01%	495
2017 Q4	$24K	Buy	+700	New	+$23.2K	0.01%	540

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Advantage Investment Management's TDOC Position: Q3 2019 in Review

Advantage Investment Management reduced its Teladoc Health (TDOC) stake by 26% in Q3 2019, selling an estimated $11K and leaving 483 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #426.

Advantage Investment Management first reported a position in TDOC in Q4 2017 and has held it in 8 quarters since. The position peaked at $73K in Q3 2018. 377 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

Advantage Investment Management held 483 shares of Teladoc Health worth $32K as of Q3 2019.
Advantage Investment Management sold 167 Teladoc Health shares in Q3 2019, an estimated $11K.
Teladoc Health made up 0.02% of Advantage Investment Management's portfolio in Q3 2019, its #426 holding.
Advantage Investment Management first reported a position in Teladoc Health in Q4 2017 and has held it in 8 quarters since.
Advantage Investment Management's Teladoc Health position peaked at $73K in Q3 2018.
377 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.